Immunolocalization of apolipoproteins in aortic atherosclerosis in American youths and young adults: Findings from the PDAY study

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 215-225

  Ishikawa, Yukio ^a   Ishii, Toshiharu ^a   Akasaka, Yoshikiyo ^a   Masuda, Takao ^a   Strong, Jack P ^b   Zieske, Arthur W ^b   Takei, Hidehiro ^b   Malcom, Gray T ^b   Taniyama, Matsuo ^c   Choi Miura, Nam Ho ^c   Tomita, Motowo ^c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Apolipoproteins; Atherosclerosis; Immunohistochemistry; Pathobiological Determinants of Atherosclerosis in Youth (PDAY)

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CLUSTERIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTA; ADULT; AGE; AORTA ATHEROSCLEROSIS; ARTERY DIAMETER; ARTERY LESION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; INTIMA; JUVENILE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUNICA MEDIA; UNITED STATES;

ADOLESCENT; ADULT; AORTA, ABDOMINAL; AORTIC DISEASES; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; CLUSTERIN; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CHAPERONES; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0034909542     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00416-6     Document Type: Article

References (46)

1. The natural history of atherosclerosis in childhood
2. The natural history of coronary atherosclerosis
3. Natural history of aortic and coronary atherosclerotic lesions in youth: Findings from the PDAY study
4. The pathogenesis of coronary artery disease and the acute coronary syndromes
5. The low density lipoprotein pathway and its relation to atherosclerosis
6. Risk factors and atherosclerotic lesions: A review of autopsy studies
7. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits
8. Natural history and risk factors for early human atherogenesis
9. Environmental and genetic risk factors in early human atherogenesis: Lesions from the PDAY study
10. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentration and smoking
11. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women
12. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue
13. A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: High and low serum thiocyanate groups as an indication of smoking
14. Immunostaning of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein (a)
15. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis
16. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase
17. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions
18. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries
19. Distribution and synthesis of apolipoprotein J in atherosclerotic aorta
20. Enzymatic determination of total serum cholesterol
21. Post-mortem serum cholesterol levels
22. Lipids in cadaver sera after fatal heart attacks
23. Lipoproteins and apolipoproteins in postmortem serum
24. A definition of the intima of human arteries and its atherosclerosis-prone regions
25. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association
26. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on arteriosclerosis, American Heart Association
27. Prevalence and extent of atherosclerosis in adolescents and young adults; implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study
28. Effect of hemodynamic factors on atherosclerosis in the abdominal aorta
29. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low and oscillating shear stress
30. The pathogenesis of atherosclerosis - An update
31. Fractionation of human serum high density lipoprotein in urea solutions: Evidence for polypeptide heterogeneity
32. Distribution of apolipoprotein A-I, C-II, C-III and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte macrophages
33. Human aortic fibrolipid lesions: Immunohistochemical localization of apolipoprotein B and apolipoprotein A
34. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques; colocalization of biglycan with apolipoproteins
35. Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions
36. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfate glycoprotein 2, a constituent of rat testis fluid
37. Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids
38. Localization of terminal complement component, S-protein and SP-40,40 in renal biopsies
39. Apolipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection
40. Mouse apolipoprotein J: Characterization of a gene implicated in atherosclerosis
41. Apolipoprotein J: Structure and tissue distribution
42. A 70-kDa apolipoprotein designated apoJ is a marker for subclasses of human plasma high density lipoproteins
43. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma
44. Interaction of high density lipoproteins with cholesterol ester-laden macro phages: Biochemical and morphological characterization of cell surface receptor binding, endocytosis and resection of high density lipoproteins by macrophages
45. Plasma high density lipoproteins: Metabolism and relationship to atherosclerosis
46. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: A potential anti-atherogenic function